Gene: MTCL1
Official Full Name: microtubule crosslinking factor 1provided by HGNC
Gene Summary: Enables microtubule binding activity. Involved in chromosome segregation. Located in kinetochore; midbody; and spindle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29587 | MTCL1 Knockout cell line (HeLa) | Human | MTCL1 | 1:3~1:6 | Negative | Online Inquiry |
KO29588 | MTCL1 Knockout cell line (HCT 116) | Human | MTCL1 | 1:2~1:4 | Negative | Online Inquiry |
KO29589 | MTCL1 Knockout cell line (HEK293) | Human | MTCL1 | 1:3~1:6 | Negative | Online Inquiry |
KO29590 | MTCL1 Knockout cell line (A549) | Human | MTCL1 | 1:3~1:4 | Negative | Online Inquiry |
MTCL1 Gene Knockout Cell Lines are advanced research tools designed to facilitate the study of the MTCL1 gene and its biological functions. Specifically engineered through CRISPR/Cas9 technology, these knockout cell lines effectively disable MTCL1 protein expression, allowing researchers to observe and analyze the resultant phenotypic changes. The mechanism of action is straightforward: the targeted deletion of specific exons in the MTCL1 gene leads to the disruption of protein synthesis, providing a valuable model for investigating the implications of MTCL1 in cellular processes such as cell proliferation, apoptosis, and response to stress.
The scientific importance of MTCL1 Gene Knockout Cell Lines cannot be overstated. As the MTCL1 gene is implicated in various cellular mechanisms, its knockout models are essential for research related to cancer, neurodegenerative diseases, and immune responses. By utilizing these cell lines, investigators can unravel the complexities of MTCL1’s role in disease pathology, providing insights that may lead to the development of therapeutic strategies.
These cell lines possess distinct advantages over traditional methods of gene manipulation, offering high specificity and efficiency with minimal off-target effects. Unlike conventional knockout models, which may rely on viral vectors or random integration methods, our CRISPR-derived lines provide precise gene editing and reproducibility, making them a superior choice for rigorous scientific investigations.
Researchers, clinicians, and pharmaceutical developers will find these MTCL1 Gene Knockout Cell Lines invaluable for accelerating the validation of drug targets, elucidating molecular pathways, or establishing new hypotheses in the realm of gene function. The detailed characterization and robust performance of these cell lines underscore their relevance in both academic and clinical research.
Our company specializes in providing high-quality biological products, underpinned by a commitment to innovation and scientific excellence. With an emphasis on precision and reliability, our MTCL1 Gene Knockout Cell Lines are a testament to our comprehensive expertise in gene-editing technologies and their application in advancing biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.